A significant population of smokers is unable or unwilling to quit smoking. As a consequence, strategies to reduce toxin exposure are being considered as a potential means of reducing tobacco-related morbidity and mortality. The purpose of this research project will be to continue to systematically examine the amount of toxin exposure across various reduction strategies and potential reduced exposure products (PREPs) using short-term, well-controlled clinical trials. In our prior TTURC project, we have focused on determining reliable and dose-responsive surrogate biomarkers for tobacco toxin exposure and risk factors for disease, and how different PREPs affect these biomarkers and the achievement of abstinence. We will expand our research efforts to better understand the underlying mechanism associated with different approaches for exposure reduction and explore factors influencing individual differences in treatment response. The focus will be on PREPs that primarily manipulate nicotine dose and closely parallels the animal studies proposed in Project 2 (Nicotine Exposure Reduction in Rats) of this TTURC. The four proposed studies involve: 1) reducing nicotine by reducing the number of cigarettes smoked; 2) reducing nicotine by reducing the nicotine yield of the cigarette smoked vs. nicotine lozenge; 3) reducing nicotine by using an antagonist treatment, nicotine vaccine; and 4) increasing nicotine by using high dose of nicotine patch with or without nicotine-free cigarettes. Subjects will be assessed at baseline, during six weeks of treatment with these products, and then during six weeks of abstinence.
The aims of the studies are to examine and compare the effects of these intervention approaches on: 1) biomarkers for tobacco toxin exposure and risk factors for disease; 2) extent of compensatory smoking, a strong determinant of toxin exposure; and 3) different aspects of tobacco addiction (e.g., physical dependence, negative affect, responses to cues, etc.). In addition, factors (genotype and phenotypes) that moderate the extent of exposure and that impact subsequent cessation will also be examined. This project, along with the TTURC projects, will provide important evidence-based data on alternative intervention methods that may potentially reduce mortality and morbidity associated with tobacco use.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA013333-08
Application #
7240422
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
8
Fiscal Year
2006
Total Cost
$343,118
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Burns, Rachel J; Rothman, Alexander J; Fu, Steven S et al. (2016) Longitudinal Care Improves Cessation in Smokers Who Do Not Initially Respond to Treatment by Increasing Cessation Self-Efficacy, Satisfaction, and Readiness to Quit: A Mediated Moderation Analysis. Ann Behav Med 50:58-69
Konorev, Dmitri; Koopmeiners, Joseph S; Tang, Yijin et al. (2015) Measurement of the Heterocyclic Amines 2-Amino-9H-pyrido[2,3-b]indole and 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Urine: Effects of Cigarette Smoking. Chem Res Toxicol 28:2390-9
Hatsukami, Dorothy K; Donny, Eric C; Koopmeiners, Joseph S et al. (2015) Compensatory smoking from gradual and immediate reduction in cigarette nicotine content. Cancer Epidemiol Biomarkers Prev 24:472-6
Burns, Rachel J; Rothman, Alexander J; Fu, Steven S et al. (2014) The relation between social support and smoking cessation: revisiting an established measure to improve prediction. Ann Behav Med 47:369-75
Oliver, Andrew J; Jensen, Joni A; Vogel, Rachel I et al. (2013) Flavored and nonflavored smokeless tobacco products: rate, pattern of use, and effects. Nicotine Tob Res 15:88-92
Knezevich, Aleksandar; Muzic, John; Hatsukami, Dorothy K et al. (2013) Nornicotine nitrosation in saliva and its relation to endogenous synthesis of N'-nitrosonornicotine in humans. Nicotine Tob Res 15:591-5
Anderson, Kristin E; Mongin, Steven J; Sinha, Rashmi et al. (2012) Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Mol Carcinog 51:128-37
Stepanov, Irina; Knezevich, Aleksandar; Zhang, Liqin et al. (2012) Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry. Tob Control 21:44-8
Kotlyar, Michael; Hertsgaard, Louise A; Lindgren, Bruce R et al. (2011) Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study. Cancer Epidemiol Biomarkers Prev 20:91-100
Joseph, Anne M; Fu, Steven S; Lindgren, Bruce et al. (2011) Chronic disease management for tobacco dependence: a randomized, controlled trial. Arch Intern Med 171:1894-900

Showing the most recent 10 out of 132 publications